⚠ Evidence note: Nutrition evidence is dominated by observational data with heavy confounding; trial endpoints are mostly surrogates, not lifespan.
Dietary Ergothioneine
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-05-08 — Ergothioneine as a potential geroprotector: Targeting molecular hallmarks of ageing and age-related diseases.: 2005–2025 systematic review consolidates mechanistic, preclinical, and longitudinal human data positioning ergothioneine (OCTN1-accumulated) as a multi-hallmark geroprotector candidate and possible aging biomarker; no new primary trial readout, calls for rigorous clinical healthspan trials. [mechanism-plausible] (novelty: 3)
Open questions
Related
Contributing findings
Ergothioneine as a potential geroprotector: Targeting molecular hallmarks of ageing and age-related diseases.
08-may-2026
novelty 3
per-area 3
strengthens